Charles River launches first CRISPR-generated immunodeficient model – OutSourcing-Pharma.com
OutSourcing-Pharma.com |
Charles River launches first CRISPR-generated immunodeficient model
OutSourcing-Pharma.com According to the company, the NCG model was developed by altering the Prkdc and Il2rg genes and is the company’s first CRISPR-generated immunodeficient model offering. Charles River previously announced its “end-to-end” service offering of … |
WLS-TV |
New form of immunotherapy uses T cells to fight cancer
WLS-TV A new form of immunotherapy called CAR-T therapy turns the immune system’s T cells into fighters. “It’s pretty amazing to see patients go into remission that we really had low hope of standard therapies working,” oncologist Frederick Locke said. Dr … |
STAT |
Immunotherapy may hasten growth of tumors in some patients
STAT or doctors at the University of California, San Diego, it was seemingly a no-lose proposition: A 73-year-old patient’s bladder cancer was slowly progressing but he was generally stable and strong. He seemed like the ideal candidate for an immunotherapy … |
Medical News Today |
Multiple sclerosis: Novel immunotherapy reverses paralysis in mice
Medical News Today For their study, Jewell and team set out to create a more precise type of immunotherapy to prevent myelin damage in MS. “The problem with current immunotherapies is that they aren’t specific,” explains Jewell. “They act broadly, compromising the entire … |
The Scientist |
CRISPR Screen Detects Functional Gene Regulation
The Scientist “It turns out that most of the genetic variation that’s responsible for more common complex diseases—like cardiovascular disease, diabetes, and neurological disorders—actually happens in this region in between genes,” said coauthor Charles Gersbach … |
|
Breast Cancer ‘Immunotherapy‘ Helps Some
WebMD MONDAY, April 3, 2017 (HealthDay News) — Women with a particularly aggressive form of breast cancer who responded to an new immune-focused drug gained a significant survival benefit, a new study shows. The patients all had what’s known as advanced … |